Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00729950
What this trial is testing

Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Malignant Melanoma
Bristol-Myers Squibb 92
Not applicableLooking for participantsNCT03823144
What this trial is testing

Intravital Microscopy in Human Solid Tumors

Who this might be right for
Solid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm+20 more
Mayo Clinic 85
Not applicableLooking for participantsNCT06934863
What this trial is testing

Rate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center Experience

Who this might be right for
Oral Lichen PlanusOral CarcinomaOral Carcinoma in Situ
Catholic University of the Sacred Heart 300
Early research (Phase 1)WithdrawnNCT03682744
What this trial is testing

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+4 more
Sorrento Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT00036764
What this trial is testing

BMS-247550 in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 88
Early research (Phase 1)Active Not RecruitingNCT04673448
What this trial is testing

Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8BRCA-Associated Malignant Neoplasm+24 more
University of Washington 18
Large-scale testing (Phase 3)Study completedNCT02286778
What this trial is testing

Eradication of Malignant Carcinoma in the Breast Tissue

Who this might be right for
Breast Cancer
Optimal Health Research 60
Very early researchWithdrawnNCT04285749
What this trial is testing

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

Who this might be right for
Malignant Melanoma
Case Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT06878248
What this trial is testing

Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer MetastaticLocally Advanced Breast Cancer (LABC)Malignant Neoplasm of Breast+3 more
Calibr, a division of Scripps Research 10
Testing effectiveness (Phase 2)Study completedNCT00237185
What this trial is testing

The Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Who this might be right for
Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)
Novartis Pharmaceuticals 148
Not applicableLooking for participantsNCT07741968
What this trial is testing

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more
City of Hope Medical Center 126
Early research (Phase 1)WithdrawnNCT00006126
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery

Who this might be right for
Breast CancerKidney CancerLung Cancer+2 more
Northwestern University
Not applicableLooking for participantsNCT06675643
What this trial is testing

Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App

Who this might be right for
Malignant Skin NeoplasmMelanoma
Mayo Clinic 100
Not applicableStudy completedNCT01610531
What this trial is testing

COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

Who this might be right for
Patients at Risk for Melanoma
Nantes University Hospital 4,118
Testing effectiveness (Phase 2)Active Not RecruitingNCT02755896
What this trial is testing

Trial to Compare Radiation Fibrosis With Five Versus Three Fractions

Who this might be right for
Malignant Neoplasm of Breast Stage I
Weill Medical College of Cornell University 350
Testing effectiveness (Phase 2)Study completedNCT02296996
What this trial is testing

Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients

Who this might be right for
Malignant Melanoma
Universitair Ziekenhuis Brussel 25
Testing effectiveness (Phase 2)Ended earlyNCT05551117
What this trial is testing

Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

Who this might be right for
Castration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more
MacroGenics 192
Not applicableUnknownNCT00963261
What this trial is testing

Quality of Life and Psychological Well-being in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
University Hospital Freiburg 600
Not applicableLooking for participantsNCT05430971
What this trial is testing

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Immune Oncology Research Institute 200
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Next Page